SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will be on a panel at the UNC Alternative Investments Conference in Chapel Hill, NC.
News | 02. 16. 2011
